BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Micha A, Psarras K, Ouroumidis O, Siska E, Vlachaki E, Lymperopoulos A, Symeonidis N, Nikolaidou C, Venizelos I, Koliakos G, Pavlidis TE. A Time Course of Bevacizumab (Anti-VEGF) Effect on Rat Peritoneum: Relations Between Antiadhesive Action and Fibrin Regulation Enzymes. Surg Innov 2017;24:543-51. [DOI: 10.1177/1553350617729510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Shi Y, Hu Y, Cui B, Zhuang S, Liu N. Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis. Perit Dial Int 2021;:8968608211004683. [PMID: 33823711 DOI: 10.1177/08968608211004683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Giannis D, Geropoulos G, Ziogas IA, Gitlin J, Oropallo A. The anti-adhesive effect of anti-VEGF agents in experimental models: A systematic review. Wound Repair Regen 2021;29:168-82. [PMID: 33316850 DOI: 10.1111/wrr.12879] [Reference Citation Analysis]
3 Jelveh Moghaddam H, Aghajani M, Raeis-abdollahi E, Faghihi M, Dabbagh A, Imani A. Decrease in VEGF-Induced Pericardial Adhesion Formation Using Bevacizumab After Surgery. Surg Innov 2019;26:21-6. [DOI: 10.1177/1553350618813451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]